Antibody Profiles to <it>P</it>. <it>falciparum</it> Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission

被引:9
|
作者
Ondigo, Bartholomew [1 ,2 ,3 ]
Hamre, Karen [4 ,5 ,6 ]
Frosch, Anne [7 ,8 ]
Ayodo, George [2 ,9 ]
White, Michael [10 ]
John, Chandy [2 ,4 ,11 ]
机构
[1] Egerton Univ, Dept Biochem & Mol Biol, Nakuru, Kenya
[2] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya
[3] NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[4] Univ Minnesota, Div Global Pediat, Minneapolis, MN USA
[5] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[6] CDC Fdn, Atlanta, GA USA
[7] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA
[8] Hennepin Healthcare Res Inst, Minneapolis, MN USA
[9] Jaram Oginga Odinga Univ Sci & Technol, Sch Hlth Sci, Siaya, Kenya
[10] Inst Pasteur, Dept Parasites & Insect Vectors, Paris, France
[11] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, 1044 W Walnut St,R4 402D, Indianapolis, IN 46202 USA
关键词
PLASMODIUM-VIVAX; LOW-PREVALENCE; INFECTION; INDIVIDUALS; POPULATION; PARASITES;
D O I
10.4269/ajtmh.19-0480
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prevalence and levels of antibodies to multiple Plasmodium falciparum antigens show promise as tools for estimating malaria exposure. In a highland area of Kenya with unstable transmission, we assessed the presence and levels of antibodies to 12 pre-erythrocytic and blood-stage P. falciparum antigens by multiplex cytometric bead assay or ELISA in 604 individuals in August 2007, with follow-up testing in this cohort in April 2008, April 2009, and May 2010. Four hundred individuals were tested at all four time points. During this period, the only substantial malaria incidence occurred from April to August 2009. Antibody prevalence in adults was high at all time points (> 70%) for apical membrane antigen 1, erythrocyte-binding antigen 175, erythrocyte-binding protein-2, glutamate rich protein (GLURP)-R2, merozoite surface protein (MSP) 1 (19), MSP-1 (42), and liver-stage antigen-1; moderate (30-70%) for GLURP-R0, MSP-3, and thrombospondin-related adhesive protein; and low (< 30%) for SE and circumsporozoite protein (CSP). Changes in community-wide malaria exposure were best reflected in decreasing antibody levels overtime for highly immunogenic antigens, and in antibody seroprevalence overtime for the less-immunogenic antigens. Over the 3 years, antibody levels to all antigens except CSP and schizont extract (SE) decreased in an age-dependent manner. Prevalence and levels of antibodies to all antigens except CSP and SE increased with age. Increases in antibody prevalence and levels to CSP and SE coincided with increases in community-wide malaria incidence. Antibody levels to multiple P. falciparum antigens decrease in the absence of consistent transmission. Multiplex assays that assess both the presence and level of antibodies to multiple pre-erythrocytic and blood-stage P. falciparum antigens may provide the most useful estimates of past and recent malaria transmission in areas of unstable transmission and could be useful tools in malaria control and elimination campaigns.
引用
收藏
页码:2189 / 2197
页数:9
相关论文
共 2 条
  • [1] Estimation of Recent and Long-Term Malaria Transmission in a Population by Antibody Testing to Multiple Plasmodium falciparum Antigens
    Ondigo, Bartholomew N.
    Hodges, James S.
    Ireland, Kathleen F.
    Magak, Ng'wena G.
    Lanar, David E.
    Dutta, Sheetij
    Narum, David L.
    Park, Gregory S.
    Ofulla, Ayub V.
    John, Chandy C.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (07) : 1123 - 1132
  • [2] Malaria Transmission and Immunity in the Kenyan Highlands Antibody Correlates of Protection from Clinical <it>Plasmodium falciparum</it> Malaria in an Area of Low and Unstable Malaria Transmission
    Hamre, Karen
    Ondigo, Bartholomew
    Hodges, James
    Dutta, Sheetij
    Theisen, Michael
    Ayodo, George
    John, Chandy
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (06) : 2174 - 2182